The Convergence of the Four Fundamental Technologies Enabling Human Evolution as A Space Faring Civilization
Abhiyantran Shastra - The Mega Journal of Engineering · 2025
DOI: 10.59875/140006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Abhiyantran Shastra - The Mega Journal of Engineering, 2025. Verfasst von Dr Rabinder Henry und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The relationship between Science, Engineering, Technology, Mathematics and Arts is the fulcrum of the modern human species. Technology, that is defined by tools and craft developed by human species has always evolved through the manipulation of fundamental units of nature including living and non-living things. This paper introduces the concept of QANG (Quantum Bits, Atoms, Neurons, and Genes) as the four foundational technologies that define the future of human evolution and as a space-faring civilizations. We explore how these domains interact, the role of artificial intelligence, and the implications for biotechnology, cognitive science, and space exploration in the evolution of the human species. The QANG convergence will ultimately bring to reality, the fictional ideas and concepts that have been envisioned over centuries.
Zitieren
APA
Henry, D. R., & Zade, D. N. (2025). The Convergence of the Four Fundamental Technologies Enabling Human Evolution as A Space Faring Civilization. Abhiyantran Shastra - The Mega Journal of Engineering. https://doi.org/10.59875/140006
Vancouver
Henry DR, Zade DN. The Convergence of the Four Fundamental Technologies Enabling Human Evolution as A Space Faring Civilization. Abhiyantran Shastra - The Mega Journal of Engineering. 2025. doi:10.59875/140006
BibTeX
@article{Henry2025,
author = {Henry, Dr Rabinder and Zade, Dr Nilima},
title = {The Convergence of the Four Fundamental Technologies Enabling Human Evolution as A Space Faring Civilization},
journal = {Abhiyantran Shastra - The Mega Journal of Engineering},
year = {2025},
doi = {10.59875/140006}
}
EUVIMED